Diagnostic and prognostic application of positron emission tomography in breast imaging: emerging uses and the role of PET in monitoring treatment response Jessica Anna CintoloJulia TchouDaniel A. Pryma Review 16 March 2013 Pages: 331 - 346
A systematic review on topoisomerase 1 inhibition in the treatment of metastatic breast cancer Iben KümlerNils BrünnerDorte L. Nielsen Review 20 March 2013 Pages: 347 - 358
Are symptomatic guidelines for chemotherapy appropriate to ER-positive screen-detected breast cancer (SDBC)? Nigel J. BundredRamachandran PrasadGill Lawrence Preclinical Study 10 July 2011 Pages: 359 - 368
PI3K/mTOR inhibition can impair tumor invasion and metastasis in vivo despite a lack of antiproliferative action in vitro: implications for targeted therapy Seth A. WanderDekuang ZhaoJoyce M. Slingerland Preclinical study Open access 21 February 2013 Pages: 369 - 381
TCH-1030 targeting on topoisomerase I induces S-phase arrest, DNA fragmentation, and cell death of breast cancer cells Yu-Peng LiuHui-Ling ChenChia-Ning Yang Preclinical study 22 February 2013 Pages: 383 - 393
The protective effect of intermittent calorie restriction on mammary tumorigenesis is not compromised by consumption of a high fat diet during refeeding Olga P. RogozinaKatai J. NkhataMargot P. Cleary Preclinical Study 28 February 2013 Pages: 395 - 406
Tumor STAT3 tyrosine phosphorylation status, as a predictor of benefit from adjuvant chemotherapy for breast cancer Amir SonnenblickBeatrice UzielyTamar Peretz Preclinical Study 28 February 2013 Pages: 407 - 413
αB-Crystallin promotes oncogenic transformation and inhibits caspase activation in cells primed for apoptosis by Rb inactivation Vladimir PetrovicDmitry MalinVincent L. Cryns Preclinical Study 08 March 2013 Pages: 415 - 425
RC0639: phase II study of paclitaxel, trastuzumab, and lapatinib as adjuvant therapy for early stage HER2-positive breast cancer Alvaro Moreno-AspitiaAmylou C. DueckEdith A. Perez Preclinical study Open access 12 March 2013 Pages: 427 - 435
Isogenic human mammary epithelial cell lines: novel tools for target identification and validation Ulrike UlbrichtAnette SommerLuisella Toschi Preclinical Study 13 March 2013 Pages: 437 - 456
PAM50 proliferation score as a predictor of weekly paclitaxel benefit in breast cancer Miguel MartÃnAleix PratPhilip S. Bernard Clinical Trial Open access 20 February 2013 Pages: 457 - 466
Effects of adjuvant tamoxifen therapy on cardiac disease: results from a randomized trial with long-term follow-up Johan RosellBo NordenskjöldJohn Carstensen Clinical Trial 02 March 2013 Pages: 467 - 473
Impact of local surgical treatment on survival in young women with T1 breast cancer: long-term results of a population-based cohort Ye Won JeonJung Eun ChoiYoung Jin Suh Clinical Trial 03 March 2013 Pages: 475 - 484
Disseminated tumour cells in the bone marrow in early breast cancer: morphological categories of immunocytochemically positive cells have different impact on clinical outcome M. SynnestvedtE. BorgenB. Naume Clinical trial 03 March 2013 Pages: 485 - 497
Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial Olöf BjarnadottirQuinci RomeroSigne Borgquist Clinical Trial 08 March 2013 Pages: 499 - 508
The HER2 status of disseminated tumor cells in the bone marrow of early breast cancer patients is independent from primary tumor and predicts higher risk of relapse A. D. HartkopfM. BanysT. Fehm Clinical Trial 15 March 2013 Pages: 509 - 517
Variation in tumor natural history contributes to racial disparities in breast cancer stage at diagnosis Nataliya G. BatinaAmy Trentham-DietzOguzhan Alagoz Epidemiology 16 February 2013 Pages: 519 - 528
A genome-wide association study to identify genetic susceptibility loci that modify ductal and lobular postmenopausal breast cancer risk associated with menopausal hormone therapy use: a two-stage design with replication Rebecca HeinDieter Flesch-JanysJenny Chang-Claude Epidemiology 20 February 2013 Pages: 529 - 542
Confirmation of the reduction of hormone replacement therapy-related breast cancer risk for carriers of the HSD17B1_937_G variant Ofure ObazeeChristina JustenhovenHiltrud Brauch Epidemiology 21 February 2013 Pages: 543 - 548
Postpartum diagnosis demonstrates a high risk for metastasis and merits an expanded definition of pregnancy-associated breast cancer Eryn B. CallihanDexiang GaoVirginia F. Borges Epidemiology Open access 22 February 2013 Pages: 549 - 559
Postoperative complications and survival of elderly breast cancer patients: a FOCUS study analysis N. A. de GlasM. KiderlenG. J. Liefers Epidemiology 28 February 2013 Pages: 561 - 569
Plasma IGF-1 and IGFBP-3 may be imprecise surrogates for breast concentrations: an analysis of healthy women Adana A. LlanosTheodore M. BraskyPeter G. Shields Epidemiology 02 March 2013 Pages: 571 - 579
Can we select individuals with low risk ductal carcinoma in situ (DCIS)? A population-based outcomes analysis Eileen RakovitchSharon Nofech-MozesLawrence Paszat Epidemiology 03 March 2013 Pages: 581 - 590
The prognostic impact of age in patients with triple-negative breast cancer Cornelia LiedtkeK. R. HessA. M. Gonzalez-Angulo Epidemiology 05 March 2013 Pages: 591 - 599
Body size throughout the life course and mammographic density in Mexican women Megan S. RiceKimberly A. BertrandIsabelle Romieu Epidemiology 05 March 2013 Pages: 601 - 610
Association between polymorphisms in apoptotic genes and susceptibility for developing breast cancer in Syrian women Bassam LajinAmir Alhaj SakurAmal Alachkar Epidemiology 07 March 2013 Pages: 611 - 619
Chronic comorbid conditions associated with risk of febrile neutropenia in breast cancer patients treated with chemotherapy Victoria M. ChiaJohn H. PageChun Chao Epidemiology 07 March 2013 Pages: 621 - 631
A trend analysis of breast cancer incidence rates in the United States from 2000 to 2009 shows a recent increase Ningqi HouDezheng Huo Brief Report 28 February 2013 Pages: 633 - 641
Too many statistical errors for meaningful interpretation A. StangE. Kantelhardt Letter to the Editor 17 February 2013 Pages: 643 - 650
Earwax type and osmidrosis: prognostic factor for breast cancer? Yang SunJianhong Long Letter to the Editor 27 February 2013 Pages: 651 - 653
Need for clarification of data in a recent meta-analysis about polymorphisms in the leptin receptor gene and risk of breast cancer Qiliu PengXianjun LaoXue Qin Letter to the Editor 19 March 2013 Pages: 655 - 656
